<DOC>
	<DOCNO>NCT02600767</DOCNO>
	<brief_summary>This vivo evaluation drug efficacy perform Cruzeiro Sul , state Acre , Brazil . A total 81 participant ≥5 year old parasitological confirmation P. falciparum monoinfection treat supervision artemether-lumefantrine three day , dose accord Brazilian guideline malaria control . The clinical parasitological parameter monitor 28-day follow-up period evaluate efficacy combination therapy . A blood sample collect filter paper first day day suspect failure try differentiate parasite genotype use technique base polymerase chain reaction . The result efficacy evaluation drug combination help Brazilian Ministry Health evaluate national policy treatment malaria cause P. falciparum .</brief_summary>
	<brief_title>Artemeter-lumefantrine Treatment P. Falciparum Malaria Brazil</brief_title>
	<detailed_description>This protocol use recommend World Health Organization ( WHO ) protocol monitor antimalarial efficacy . Patients malaria receive supervise therapy monitor 28 day check treatment response , clinically parasitologically . A total 81 participant ≥5 year old parasitological confirmation P. falciparum monoinfection treat supervision artemether-lumefantrine three day , dose accord Brazilian guideline malaria control . The clinical parasitological parameter monitor 28-day follow-up period evaluate efficacy combination therapy . Patients ask come back Days 2 , 3 , 7 , 14 , 21 28 clinical evaluation blood test use microscopy . A blood sample collect filter paper first day day suspect failure try differentiate parasite genotype use technique base polymerase chain reaction , allow u determine recurrent infection reinfection failure recrudescence . Results evaluation guide treatment policy Brazil .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<criteria>&gt; = 5 year body weight &lt; 120kg document fever ( axillary temperature ≥37.5o C ) history fever previous 48 hour absence obvious cause fever , pneumonia , middle ear infection , etc . monoinfection P. falciparum parasitemia 250 200,000 asexual parasites/µl , determine swab thick peripheral blood smear microscopic exam patient parent/caregiver able comprehend sign inform consent permission form patient age 717 year able provide assent , patient age 56 year require assent willingness return clinic and/or accept home visit regular checkup 28day followup period hemoglobin level ≥8 g/dl Exclusion Criteria presence malaria danger sign ( inability drink , vomit ( twice previous 24 hour ) , recent history seizure ( one previous 24 hour ) , alter level consciousness , inability sit stand ) ; presence sign severe malaria ( altered level consciousness , psychomotor alteration , seizure , torpor irreversible coma ) , severe anemia ( hematocrit &lt; 15 % clinical sign , hemoglobin &lt; 5 g/dl ) , renal failure ( serum creatinine &gt; 3 mg/dl clinical sign ) , pulmonary edema , hypoglycemia ( blood glucose &lt; 40 mg/dl clinical sign ) , shock ( systolic blood pressure &lt; 70 mmHg adult ; &lt; 50 mmHg child ) , spontaneous hemorrhage/disseminated intravascular coagulation , repeat generalized seizure , acidemia/acidosis ( clinical sign ) , macroscopic hemoglobinuria , jaundice . history chronic severe underlying disease ( e.g . heart , renal liver disease , HIV/AIDS , tuberculosis , malnourishment ) history hypersensitivity AL current pregnancy ( history current pregnancy positive pregnancy test ) use antimalarial drug previous 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>